{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:48:11Z","timestamp":1789681691087,"version":"4.0.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guangxi Natural Science Foundation","award":["2024JJB140352"],"award-info":[{"award-number":["2024JJB140352"]}]},{"name":"Innovation Project of Guangxi Graduate Education of GXUCM","award":["YCBXJ2023040"],"award-info":[{"award-number":["YCBXJ2023040"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,7]]},"abstract":"<jats:p>The identification of suitable biomarkers holds significant clinical importance for the early detection of benign prostatic hyperplasia (BPH) and prostate cancer (PCa). This study aimed to conduct a comprehensive analysis of the relationship between BPH and blood and urine biomarkers (BUB), as well as PCa and BUB. Candidate single nucleotide polymorphisms associated with BPH or PCa were derived from recent genome-wide association studies. The UK Biobank cohort comprised 363,228 individuals with BUB test data, enabling the calculation of a polygenic risk score for BPH or PCa. Bidirectional 2-sample Mendelian randomization was employed to assess the potential causal association between candidate BUB and BPH, as well as between BUB and PCa. In this study, a notable correlation was observed between BPH and gamma-glutamyl transferase (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20051.061658447, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.028697428). PCa exhibited significant associations with insulin-like growth factor 1 (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20051.119051258, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.004101067), Lipoprotein A (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20051.120348291, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.038093372), total protein (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20050.87643517, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.01657563), and non-albumin protein (<jats:italic toggle=\"yes\">r<\/jats:italic>\u2005=\u20050.905333153, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.03103913). The findings offer valuable insights into the significance of BUB in the timely identification and management of BPH and PCa.<\/jats:p>","DOI":"10.1097\/md.0000000000041723","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:56:11Z","timestamp":1743206171000},"page":"e41723","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The association between benign and malignant prostatic hyperplastic diseases and blood and urine biomarkers: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Ze-sen","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Urology, The Second People\u2019s Hospital of Zhaoqing, Zhaoqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-chao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine Surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China"},{"name":"Department of Graduate School, Guangxi University of Chinese Medicine, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-lan","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Graduate School, Guangxi University of Chinese Medicine, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-ping","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Graduate School, Guangxi University of Chinese Medicine, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di-kuan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second People\u2019s Hospital of Zhaoqing, Zhaoqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-zhong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second People\u2019s Hospital of Zhaoqing, Zhaoqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-xiong","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second People\u2019s Hospital of Zhaoqing, Zhaoqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5900-5330","authenticated-orcid":false,"given":"Min","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine Surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China"},{"name":"Department of Graduate School, Guangxi University of Chinese Medicine, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-jian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second People\u2019s Hospital of Zhaoqing, Zhaoqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250328","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.15229","article-title":"Benign prostatic hyperplasia - what do we know?","volume":"127","author":"Devlin","year":"2021","journal-title":"BJU Int"},{"key":"R2-20250328","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.purol.2018.08.005","article-title":"Donn\u00e9es \u00e9pid\u00e9miologiques en rapport avec la prise en charge de l\u2019HBP [Epidemiology of benign prostatic hyperplasia].","volume":"28","author":"Robert","year":"2018","journal-title":"Prog Urol"},{"key":"R3-20250328","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00345-019-02691-0","article-title":"What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?","volume":"37","author":"Foo","year":"2019","journal-title":"World J Urol"},{"key":"R4-20250328","first-page":"843","article-title":"Current treatment for benign prostatic hyperplasia.","volume":"117","author":"Miernik","year":"2020","journal-title":"Dtsch Arztebl Int"},{"key":"R5-20250328","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.3390\/ijms232214257","article-title":"Complexities of prostate cancer.","volume":"23","author":"Wasim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R6-20250328","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches.","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"R7-20250328","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/cancers16101835","article-title":"Prognostic significance of the royal marsden hospital (RMH) score in patients with cancer: a systematic review and meta-analysis.","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R8-20250328","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.3390\/cancers16213689","article-title":"Prognostic value of neutrophil-to-eosinophil ratio (NER) in cancer: a systematic review and meta-analysis.","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R9-20250328","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/10717544.2018.1440666","article-title":"Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-\u03b1, TRAIL, and interleukin-12.","volume":"25","author":"Altwaijry","year":"2018","journal-title":"Drug Deliv"},{"issue":"R1","key":"R10-20250328","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R11-20250328","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ije\/dyaa101","article-title":"Corrigendum to: An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings.","volume":"49","author":"Sanderson","year":"2020","journal-title":"Int J Epidemiol"},{"key":"R12-20250328","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41588-020-00757-z","article-title":"Genetics of 35 blood and urine biomarkers in the UK Biobank [published correction appears in Nat Genet. 2021 Nov;53(11):1622].","volume":"53","author":"Sinnott-Armstrong","year":"2021","journal-title":"Nat Genet"},{"key":"R13-20250328","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration.","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"R14-20250328","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12967-022-03722-y","article-title":"Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study.","volume":"20","author":"Wang","year":"2022","journal-title":"J Transl Med"},{"key":"R15-20250328","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4078\/jrd.2020.27.4.241","article-title":"Overview of Mendelian randomization analysis.","volume":"27","author":"Lee","year":"2020","journal-title":"J Rheum Dis"},{"key":"R16-20250328","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s40520-023-02669-4","article-title":"The relationship between circulating metabolites and prostate hyperplasia: a Mendelian randomization study.","volume":"36","author":"Zhang","year":"2024","journal-title":"Aging Clin Exp Res"},{"key":"R17-20250328","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1002\/jmv.28008","article-title":"Association between COVID-19 and telomere length: a bidirectional Mendelian randomization study.","volume":"94","author":"Huang","year":"2022","journal-title":"J Med Virol"},{"key":"R18-20250328","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.2","article-title":"Guidelines for performing Mendelian randomization investigations.","volume":"4","author":"Burgess","year":"2020","journal-title":"Wellcome Open Res"},{"key":"R19-20250328","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/nu15041057","article-title":"No evidence of a genetic causal relationship between ankylosing spondylitis and gut microbiota: a two-sample Mendelian randomization study.","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"key":"R20-20250328","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.34408","article-title":"The MR-base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R21-20250328","doi-asserted-by":"crossref","first-page":"647588","DOI":"10.3389\/fimmu.2021.647588","article-title":"Circulating interleukins and risk of multiple sclerosis: a Mendelian randomization study.","volume":"12","author":"Lu","year":"2021","journal-title":"Front Immunol"},{"key":"R22-20250328","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12885-017-3301-x","article-title":"Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.","volume":"17","author":"Kawakami","year":"2017","journal-title":"BMC Cancer"},{"key":"R23-20250328","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1590\/S0004-27302009000800010","article-title":"IGF-I, insulin and prostate cancer.","volume":"53","author":"Lima","year":"2009","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"R24-20250328","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/CEJ.0b013e328359cba7","article-title":"Lipoprotein(a) plasma levels and the risk of cancer: the PRIME study.","volume":"22","author":"Marrer","year":"2013","journal-title":"Eur J Cancer Prev"},{"key":"R25-20250328","doi-asserted-by":"crossref","first-page":"e1003859","DOI":"10.1371\/journal.pmed.1003859","article-title":"The relationship between lipoprotein A and other lipids with prostate cancer risk: a multivariable Mendelian randomisation study.","volume":"19","author":"Ioannidou","year":"2022","journal-title":"PLoS Med"},{"key":"R26-20250328","doi-asserted-by":"crossref","first-page":"e1003988","DOI":"10.1371\/journal.pmed.1003988","article-title":"Association between genetically proxied PCSK9 inhibition and prostate cancer risk: a Mendelian randomisation study.","volume":"20","author":"Fang","year":"2023","journal-title":"PLoS Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T19:20:41Z","timestamp":1743362441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041723","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}